Cargando…

Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells

Our previous studies have demonstrated that epidermal growth factor (EGF) can induce cell migration through the induction of cysteine-rich protein 61 (Cyr61) in human anaplastic thyroid cancer (ATC) cells. The aim of the present study was to determine the inhibitory effects of combined treatment wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chin, Li-Han, Hsu, Sung-Po, Zhong, Wen-Bin, Liang, Yu-Chih
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351011/ https://www.ncbi.nlm.nih.gov/pubmed/25742642 http://dx.doi.org/10.1371/journal.pone.0118674

Ejemplares similares

Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells
por: Chin, Li-Han, et al.
Publicado: (2017)

A Synergistic Anti-Cancer Effect of Troglitazone and Lovastatin in a Human Anaplastic Thyroid Cancer Cell Line and in a Mouse Xenograft Model
por: Zhong, Wen-Bin, et al.
Publicado: (2018)

Simvastatin Inhibits Cell Proliferation and Migration in Human Anaplastic Thyroid Cancer
por: Chen, Mei-Chieh, et al.
Publicado: (2017)

Cysteine-rich 61 (Cyr61): a biomarker reflecting disease activity in rheumatoid arthritis
por: Fan, Yong, et al.
Publicado: (2019)

Cysteine-Rich Protein 61 Plays a Proinflammatory Role in Obstructive Kidney Fibrosis
por: Lai, Chun-Fu, et al.
Publicado: (2013)

Prognostic significance of expression of cysteine-rich 61 and cyclooxygenase-2 in gastric cancer
por: Wang, Yan, et al.
Publicado: (2016)

Critical Role of Cysteine-Rich Protein 61 in Mediating the Activation of Renal Fibroblasts
por: Liu, Hang, et al.
Publicado: (2019)

Troglitazone and Δ2Troglitazone Enhance Adiponectin Expression in Monocytes/Macrophages through the AMP-Activated Protein Kinase Pathway
por: Tsai, Jaw-Shiun, et al.
Publicado: (2014)

Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer
por: Li, Xinpeng, et al.
Publicado: (2018)

Targeting cysteine-rich angiogenic inducer-61 by antibody immunotherapy suppresses growth and migration of non-small cell lung cancer
por: Li, Xinpeng, et al.
Publicado: (2022)

In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer
por: Fujita, Megumi, et al.
Publicado: (2017)

Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells
por: Gao, Lan, et al.
Publicado: (2017)

Urinary Cysteine-Rich Protein 61 and Trefoil Factor 3 as Diagnostic Biomarkers for Colorectal Cancer()
por: Shimura, Takaya, et al.
Publicado: (2019)

Effect of troglitazone on radiation sensitivity in cervix cancer cells
por: An, Zhengzhe, et al.
Publicado: (2012)

Study of Cysteine-Rich Protein 61 Genetic Polymorphism in Predisposition to Fracture Nonunion: A Case Control
por: Ali, Sabir, et al.
Publicado: (2015)

Diagnostic value of using exosome-derived cysteine-rich protein 61 as biomarkers for acute coronary syndrome
por: Li, Wei, et al.
Publicado: (2021)

Troglitazone reverses the multiple drug resistance phenotype in cancer cells
por: Davies, Gerald F, et al.
Publicado: (2009)

Troglitazone and tumor inhibition: an evolving concept in the management of systemic malignancies
por: Kapoor, Shailendra
Publicado: (2012)

Blood‐based detection of lung cancer using cysteine‐rich angiogenic inducer 61 (CYR61) as a circulating protein biomarker: a pilot study
por: Ac\ˇkar, Lucija, et al.
Publicado: (2021)

Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: JIE, LI-GANG, et al.
Publicado: (2015)

Role of cysteine-rich angiogenic inducer 61 in fibroblast-like synovial cell proliferation and invasion in rheumatoid arthritis
por: Jie, Li-Gang, et al.
Publicado: (2022)

Downregulation of secreted protein acidic and rich in cysteine in human trabecular meshwork cells
por: Fu, Yang, et al.
Publicado: (2021)

Inhibition of cell motility by troglitazone in human ovarian carcinoma cell line
por: Yang, Yuh-Cheng, et al.
Publicado: (2007)

Antiproliferative effects and molecular mechanisms of troglitazone in human cervical cancer in vitro
por: Ye, Jinjun, et al.
Publicado: (2015)

A Retrospective Review of Thiazolidinediones with Development of a Troglitazone Conversion Protocol
por: Lindsey, Cameron, et al.
Publicado: (2003)

Cysteine-Rich Angiogenic Inducer 61 Serves as a Potential Serum Biomarker for the Remission of Adult-Onset Still's Disease
por: Su, Yutong, et al.
Publicado: (2019)

Cysteine-Rich Angiogenic Inducer 61: Pro-Survival Function and Role as a Biomarker for Disseminating Breast Cancer Cells
por: Bartkowiak, Kai, et al.
Publicado: (2021)

BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients
por: Wu, Yu, et al.
Publicado: (2019)

Anoctamin-1 affects the migration and invasion of anaplastic thyroid carcinoma cells
por: Kim, Jae-Young, et al.
Publicado: (2019)

Troglitazone Induces Extracellular Matrix and Cytoskeleton Remodeling in Mouse Collecting Duct Cells
por: Corinaldi, Jaime, et al.
Publicado: (2012)

Anaplastic Thyroid Carcinoma
por: Taccaliti, Augusto, et al.
Publicado: (2012)

CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer
por: Huang, Li-Chi, et al.
Publicado: (2018)

Cross-sectional and longitudinal associations of serum Cysteine-rich 61 with severity and prognosis among community-acquired pneumonia patients in China
por: Yao, Meng-Xing, et al.
Publicado: (2022)

Structural basis for the biosynthesis of lovastatin
por: Wang, Jialiang, et al.
Publicado: (2021)

Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines
por: Nobuhara, Y, et al.
Publicado: (2005)

Associations between urinary cysteine-rich protein 61 excretion and kidney function decline in outpatients with chronic kidney disease: a prospective cohort study in Taiwan
por: Lai, Chun-Fu, et al.
Publicado: (2021)

Anticancer Activity of Metformin, an Antidiabetic Drug, Against Ovarian Cancer Cells Involves Inhibition of Cysteine-Rich 61 (Cyr61)/Akt/Mammalian Target of Rapamycin (mTOR) Signaling Pathway
por: Zhang, Fengli, et al.
Publicado: (2018)

Troglitazone Reduces Glyoxalase I Protein Expression in Glioma and Potentiates the Effects of Chemotherapeutic Agents
por: Helgager, Jeffrey, et al.
Publicado: (2010)

Integrative Toxicoproteomics Implicates Impaired Mitochondrial Glutathione Import as an Off-Target Effect of Troglitazone
por: Lee, Yie Hou, et al.
Publicado: (2013)

Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy
por: Park, Hyunju, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b6vmds3om6di6h248hr7273kiu